Page 1 of 3     

Quantity: 1ml. Format: Lyophilized supernatant. Description: Epitope "a? (AFP). ISOBM TD-2 approved (cluster B)

Quantity: 1ml. Format: Lyophilized supernatant. Description: Epitope "b?

Quantity: 1ml. Format: Lyophilized supernatant. Description: High affinity, well suited for the detection of traces of BSA in tissue culture products or other preparations. Not cross-reacting with HSA.

Quantity: 100µg. Format: Purified. Description: Fuca1-2Gal beta1-4GlcNAc beta1. Partially cross-reacting with Lewis Y. HLDA7 approved

Quantity: 1ml. Format: Lyophilized supernatant. Description: Cross-reacting with H type 2 and Leb

Quantity: 1ml. Format: Lyophilized supernatant. Description: Gal beta1-3GalNAc-(TF alpha > TF beta) comparable to A78-G/A7, but cross-reacting in ELISA with GlcNAcbeta1-6[Gal1-3]GalNAc-, Core-2), cluster of 2 TFs at a distance of about 13 aa

Quantity: 1ml. Format: Lyophilized supernatant. Description: Gal beta1-3GalNAc-(Nemod-TF1) (TFalpha >> TFbeta) Capable to bind single TFs, not cross-reactive with Core-2

Quantity: 1ml. Format: Lyophilized supernatant. Description: TFalpha on glycophorin (mixed epitope in the extracellular domain, aa 34-55), aGP only (aGP = asiologlycophorin)

Quantity: 1ml. Format: Lyophilized supernatant. Description: Gal beta1-3GalNAcbeta1-(TF beta)

Quantity: 1ml. Format: Lyophilized supernatant. Description: Gal beta1-3GalNAcbeta1-(TF beta)

1

2

3